Fortis Hospital hosts interactive session with village heads to boost rural family health awareness
Fortis Hospital in Ludhiana, Punjab, recently organized a meeting with sarpanches (village heads) from Ludhiana and surrounding villages. The event aimed to build stronger partnerships with the community and raise awareness about the importance of family health, disease prevention, and early medical care in rural areas. The meeting was attended by senior doctors and officials from the hospital, including Dr. Vishavdeep Goyal, SBU Head and Zonal Director, and sarpanches from various villages.
The event highlighted the crucial role that sarpanches play in improving the health of their communities. Gurpreet Singh, a sarpanch from Pind Uppal, emphasized that sarpanches are the bridge between healthcare services and families, guiding villagers towards preventive care and ensuring that no one is left behind. He expressed his appreciation for the collaboration with Fortis Hospital, calling it a landmark initiative in transforming rural healthcare.
The meeting featured insightful health talks by senior Fortis specialists, Dr. Sanjeev Mahajan, Director of Orthopaedics, and Dr. Paramdeep Singh Sandhu, Director of Cardiology. The talks focused on the importance of early medical care and disease prevention, and provided valuable information on various health topics.
As a token of appreciation, Fortis Hospital announced the launch of a customized Fortis Privilege Card exclusively for sarpanches and their families. The card offers significant discounts on outpatient consultations, inpatient admissions, and diagnostic investigations, making top-tier healthcare more accessible to the families of sarpanches.
The event concluded with a joint pledge to collaborate on future health initiatives for rural families. The partnership between Fortis Hospital and the sarpanches is expected to have a positive impact on the health and wellbeing of rural communities in Punjab. By working together, they aim to promote health awareness, improve access to healthcare services, and ultimately transform rural healthcare in the region. The Fortis Privilege Card is a significant step towards achieving this goal, and is expected to benefit many families in the years to come.
Kiran Mazumdar-Shaw hails Namma Metro as a solution to traffic woes, praising BMRCL for a ‘great ride’.
Kiran Mazumdar-Shaw, the executive chairperson of Biocon, took to social media to express her admiration for the Namma Metro, Bengaluru’s metro rail system. She tweeted about her experience of using the metro to commute, praising the service and thanking the Bangalore Metro Rail Corporation Limited (BMRCL) for providing a convenient and efficient mode of transportation.
Mazumdar-Shaw, who is one of India’s most successful entrepreneurs, revealed that she had taken the metro to beat the city’s notorious traffic congestion. By using the metro, she was able to avoid the chaos and reach her destination quickly. Her tweet read: “Took Namma Metro from MG Road to Peenya…great ride, thanks BMRCL! Beats the traffic chaos! Must use it more often!”
The business leader’s endorsement of the metro service is significant, as it highlights the effectiveness of the public transportation system in Bengaluru. The city is known for its congested roads and traffic jams, and the metro has been a game-changer for commuters. With its efficient and reliable service, the metro has become a popular mode of transportation for many citizens.
Mazumdar-Shaw’s experience is not an isolated one. Many Bengalureans have taken to social media to praise the metro service, citing its convenience, cleanliness, and punctuality. The BMRCL has been working to expand the metro network, with new lines and stations being added regularly. The metro has also been integrated with other modes of transportation, such as buses and autos, making it easier for commuters to travel across the city.
The success of the Namma Metro is a testament to the city’s efforts to improve its infrastructure and reduce congestion. As Bengaluru continues to grow and develop, the metro will play an increasingly important role in keeping the city moving. With entrepreneurs like Kiran Mazumdar-Shaw endorsing the service, it’s likely that more people will turn to the metro as a reliable and efficient mode of transportation.
Overall, Mazumdar-Shaw’s tweet has highlighted the benefits of using the Namma Metro and has encouraged others to do the same. As the city’s traffic woes continue to plague commuters, the metro provides a convenient and efficient alternative. With its expanding network and improved services, the Namma Metro is set to become an integral part of Bengaluru’s transportation landscape.
Apollo Hospitals Introduces ‘Fleet of Hope’ on World Emergency Medicine Day to Promote Awareness About 1066 Emergency Services
On World Emergency Medicine Day, Apollo Hospitals launched the “Fleet of Hope” initiative to raise awareness about its 1066 emergency services. The campaign aims to educate the public about the importance of emergency medical services and the role they play in saving lives. The “Fleet of Hope” consists of a fleet of ambulances that will travel across the city, spreading awareness about the 1066 emergency services and providing medical assistance to those in need.
The 1066 emergency services are a 24/7 emergency response system that provides immediate medical attention to patients in critical condition. The service is equipped with state-of-the-art medical equipment and staffed by trained emergency medical technicians and doctors. The service can be accessed by dialing the toll-free number 1066, and it is available to anyone in need of emergency medical assistance.
The “Fleet of Hope” initiative is part of Apollo Hospitals’ efforts to raise awareness about the importance of emergency medical services and to promote the use of the 1066 emergency services. The campaign will involve a series of activities, including roadshows, awareness rallies, and community outreach programs. The fleet of ambulances will be equipped with medical equipment and staffed by medical professionals who will provide free medical check-ups and consultations to the public.
Apollo Hospitals has been at the forefront of emergency medical services in the country, and the “Fleet of Hope” initiative is a testament to the hospital’s commitment to providing quality medical care to those in need. The hospital’s emergency services have been instrumental in saving countless lives, and the “Fleet of Hope” initiative aims to take this mission forward.
The “Fleet of Hope” initiative was launched on World Emergency Medicine Day, which is observed on May 20th every year. The day is dedicated to raising awareness about the importance of emergency medical services and to recognizing the efforts of emergency medical professionals who work tirelessly to save lives. The launch of the “Fleet of Hope” initiative is a significant milestone in Apollo Hospitals’ efforts to promote emergency medical services and to provide quality medical care to those in need.
Overall, the “Fleet of Hope” initiative is a commendable effort by Apollo Hospitals to raise awareness about the importance of emergency medical services and to promote the use of the 1066 emergency services. The campaign has the potential to make a significant impact on the community and to save countless lives. By providing free medical check-ups and consultations, the “Fleet of Hope” initiative aims to educate the public about the importance of emergency medical services and to promote the use of the 1066 emergency services.
Biocon Biologics Renews Long-Term Agreement to Supply Insulin to Malaysia’s Ministry of Health.
Biocon Biologics, a leading global biopharmaceutical company, has announced the extension of its insulin supply contract with the Ministry of Health in Malaysia. The contract, which was initially signed in 2019, has been extended for another three years, demonstrating the company’s commitment to providing affordable and high-quality insulin to the Malaysian market.
Under the contract, Biocon Biologics will continue to supply its recombinant human insulin (rh-insulin) products, including Insugen and Basalog, to the Malaysian government. These products will be used to support the country’s national healthcare system, providing essential treatment for patients with diabetes. The extended contract is expected to benefit over 300,000 patients in Malaysia who rely on insulin therapy.
Biocon Biologics’ insulin products have been widely accepted in Malaysia due to their high quality, efficacy, and affordability. The company’s rh-insulin products are manufactured at its state-of-the-art facility in Bangalore, India, which has been inspected and approved by regulatory agencies in several countries, including the US FDA and the EU’s EMA.
The extension of the contract is a significant milestone for Biocon Biologics, as it reinforces the company’s position as a trusted partner for governments and healthcare systems worldwide. The company’s commitment to providing affordable and accessible healthcare solutions has made a significant impact in Malaysia, where diabetes is a growing health concern.
According to the International Diabetes Federation, Malaysia has one of the highest prevalence rates of diabetes in Asia, with over 3.5 million people living with the condition. The extended contract will enable Biocon Biologics to continue playing a vital role in supporting the Malaysian government’s efforts to combat diabetes and improve healthcare outcomes for patients.
Biocon Biologics’ CEO, Christiane Hamacher, commented, “We are proud to extend our partnership with the Malaysian Ministry of Health, demonstrating our commitment to providing high-quality, affordable insulin to patients in need. Our insulin products have made a significant impact in Malaysia, and we look forward to continuing our collaboration to improve healthcare outcomes for patients with diabetes.” The contract extension is a testament to Biocon Biologics’ dedication to making a positive impact on global healthcare, and the company is well-positioned to continue its mission of providing innovative and affordable healthcare solutions to patients worldwide.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.